Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes Mellitus
1 other identifier
observational
199
0 countries
N/A
Brief Summary
This study was a cross-sectional, observational design without involving random grouping or intervention. From July 2026 to June 2027, 199 children with type 1 diabetes who had received insulin treatment for at least 6 months and their main family caregivers were recruited by a continuous enrollment method from the endocrinology department of a tertiary children's hospital in Zhejiang Province. Qualified investigators conducted on-site distribution and collection of structured questionnaires, collecting general information of the children, the occurrence of skin complications, and the insulin injection behaviors of the caregivers. At the same time, personnel with ultrasound qualifications used a wireless handheld ultrasound combined with a skin lipid caliper to uniformly measure the subcutaneous fat thickness at 8 sites including the abdomen, buttocks, arms, and thighs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2027
May 29, 2026
February 1, 2026
7 months
April 30, 2026
May 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of insulin injection-related lipohypertrophy
The proportion of children with type 1 diabetes who are identified as having insulin injection-related lipohypertrophy. Lipohypertrophy will be determined as present if it is detected by physical examination and/or ultrasound assessment; results from these assessments will be combined into a single yes/no determination for each participant and reported as a proportion.
2026.07-2027.06
Eligibility Criteria
Children diagnosed with type 1 diabetes and receiving insulin treatment, along with their primary family caregivers
You may qualify if:
- Patient meets the diagnostic criteria for T1DM recommended by WHO and is diagnosed with T1DM.
- Patient was diagnosed with T1DM for \>= 6 months.
- Patient has no cognitive or awareness disorders and has the ability to read.
- Patient agrees to participate in this study.
- Patient's family caregiver has a certain level of comprehension ability, is conscious and clear-minded during the survey, and can answer freely.
- Patient's family caregiver voluntarily participates in the survey.
- Patient's family caregiver provides an average daily care time for the child of \>= 6 hours.
You may not qualify if:
- Patient has acute or chronic complications of diabetes and is unable to cooperate, requiring urgent treatment.
- Patient is in a state of disease stress, such as acute infection, surgery, trauma, etc., and is difficult to cooperate with the research.
- Patient's family caregiver has unconsciousness or abnormal mental state.
- Patient's family caregiver has hearing or language disorders.
- Patient or patient's family caregiver has already participated in this survey.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2026
First Posted
May 29, 2026
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 29, 2026
Record last verified: 2026-02